Prophylactic cardiac treatment in DMD patients is associated with a 54% lower hazard of death, highlighting its potential survival benefit. Only 27.7% of DMD patients received prophylactic cardiac ...

Lenacapavir is a twice-yearly injectable medication designed to be used as pre-exposure prophylaxis (PrEP). The FDA is giving ...

Experts discuss PPI use for GI protection in patients on antithrombotics, highlighting risk factors, dosing, drug ...

The Clinical Guidelines Committee of the American College of Physicians (ACP) has released a new clinical guideline on the prevention of episodic migraine headache in nonpregnant adults in the ...

A prophylactic antibody-based immune therapy protects monkeys against severe disease caused by H5N1 avian flu, University of Pittsburgh and NIH Vaccine Research Center researchers report in Science.

These practices are relatively harmless and may reduce precompetition anxiety, but a concerning ritual that has recently developed in sports is the prophylactic use of non-steroidal anti-inflammatory ...

especially if the current treatment isn’t effective. A 2022 study found that only 24.9% of patients remained on their prescribed migraine prophylactic after 24 months. Among all patients ...

CSL and uniQure's Hemgenix shows sustained efficacy in hemophilia B, reducing bleeding rates by 90% and eliminating ...

Pharvaris (PHVS) is climbing 3% after investment bank JMP Securities raised its price target on the shares to $55, based on its optimism about the company's prophylactic treatment for Hereditary ...

Defibrotide prophylaxis after HSCT did not reduce sinusoidal obstructive syndrome incidence in high-risk pediatric patients, per retrospective study at 2025 Tandem Meeting.

Data from the Phase III FRONTIER3 trial found that 98% of caregivers prefer Mim8 for hemophilia A over other treatments.